바이오라이프 솔루션 (BLFS) 주가

바이오라이프 솔루션(BLFS)는 NASDAQ에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $36.88 (+0.08%), 시가총액 $1.09B, 52주 최저~최고 $18.15 ~ $28.79.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible trans

핵심 지표

• 현재가: $36.88 (+0.08%)
• 시가총액: $1.09B
• 52주 최저~최고: $18.15 ~ $28.79
• 섹터: Healthcare
• 산업: Medical Instruments & Supplies
• 거래소: NASDAQ

바이오라이프 솔루션의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

바이오라이프 솔루션 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.7778

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.89
• 순이익률: -0.03%
• 영업이익률: 0.00%

자주 묻는 질문